Skip to main content
SpringerLink
Log in

Hormonanalytik zur Zyklusdiagnostik

  • Chapter
Kinderwunschsprechstunde

  • 218 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adashi EY, Resnick CE, D'Ercole AJ et al. (1985) Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev 6:400–420

    PubMed  Google Scholar 

  • Azziz R, Black VY, Knochenhauer ES et al. (1999) Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level. J Clin Endocrinol Metab. 84:946–950

    Article  PubMed  Google Scholar 

  • Barbieri RL, Gochberg J, Ryan KJ (1986) Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro. J Clin Invest. 77:1727–1733

    PubMed  Google Scholar 

  • Bayrak A, Saadat Purwit-ane R, Chong L et al. (2003) Hyperprolactinemia: guidelines for clinical assessment and pituitary imaging. Fertil Steril 79(Suppl 2):6

    Article  Google Scholar 

  • Bentley PJ (1980) Endocrine pharmacology. Cambridge Univ Press, Cambridge, p 197

    Google Scholar 

  • Bider D, Amoday I, Tur-Kaspa I et al. (1996) The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization—a randomized study. Hum Reprod 11:1606–1608

    PubMed  Google Scholar 

  • Bider D, Amoday I, Yonesh M et al. (1996) Glucocorticoid administration during transfer of frozen-thawed embryos: a prospective, randomized study. Fertil Steril 66:154–156

    PubMed  Google Scholar 

  • Biller BM, Molitch ME, Vance ML et al. (1996) Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 81:2338–2343

    Article  PubMed  Google Scholar 

  • Bohnet HG, Fiedler K, Leidenberger FA (1981) Subclinical hypothyroidism and infertility. Lancet 2:1278

    Article  Google Scholar 

  • Bukman A, Heineman MJ (2001) Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 7:581–590

    Article  PubMed  Google Scholar 

  • Ciccarelli E, Giusti M, Miola C et al. (1989) Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients. J Clin Endocrinol Metab 69:725–728

    PubMed  Google Scholar 

  • Coetzee EJ, Jackson WP (1979) Diabetes newly diagnosed during pregnancy: A 4-year study at Groote Schuur Hospital. S Afr Med J 56:467–475

    PubMed  Google Scholar 

  • Coetzee EF, Jackson WP (1984) Oral hypoglycaemics on the first trimester and fetal outcome. S Afr Med J 65:635–637

    PubMed  Google Scholar 

  • Coetzee EJ, Jackson WP (1985) The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res Clin Pract 1:281–287

    PubMed  Google Scholar 

  • Colao A, Di Sarno A, Sarnacchiaro F et al. (1997) Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab 82:876–883

    Article  PubMed  Google Scholar 

  • Colao A, Di Sarno A, Landi ML et al. (1997) Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage. J Clin Endocrinol Metab 82:3574–3579

    Article  PubMed  Google Scholar 

  • Colao A, Di Sarno A, Landi ML et al. (2000) Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab 85:2247–2252

    Article  PubMed  Google Scholar 

  • Colao A, Di Sarno A, Cappabianca P et al. (2003) Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med. 349:2023–2033

    Article  PubMed  Google Scholar 

  • Crave JC, Fimbel S, Lejeune H et al. (1995) Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 80:2057–2062

    Article  PubMed  Google Scholar 

  • Dunaif A (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774–800

    Article  PubMed  Google Scholar 

  • Ferrari C, Mattei A, Melis GB et al. (1989) Cabergoline: long-acting oral treatment of hyperprolactinemic disorders. J Clin Endocrinol Metab 68:1201–1206

    PubMed  Google Scholar 

  • Ferrari C, Paracchi A, Mattei AM et al. (1992) Cabergoline in the long-term therapy of hyperprolactinemic disorders. Acta Endocrinol (Copenh) 126:489–494

    PubMed  Google Scholar 

  • Ferrari CI, Abs R, Bevan JS et al. (1997) Treatment of macroprolactinoma with cabergoline: a study of 85 patients. Clin Endocrinol (Oxf) 46:409–413

    Article  Google Scholar 

  • Franks S, Gilling-Smith C, Watson H et al. (1999) Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am 28:361–378

    Article  PubMed  Google Scholar 

  • Ghazeeri G, Kutteh WH, Bryer-Ash M et al. (2003) Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 79:562–566

    Article  PubMed  Google Scholar 

  • Glueck CJ, Phillips H, Cameron D et al. (2001) Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril 75:46–52

    Article  PubMed  Google Scholar 

  • Glueck CJ, Wang P, Kobayashi S et al. (2002a) Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 77:520–525

    Article  PubMed  Google Scholar 

  • Glueck CJ, Wang P, Goldenberg N et al. (2002b) Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 17:2858–2864

    Article  PubMed  Google Scholar 

  • Glueck CJ, Goldenberg N, Pranikoff J et al. (2004a) Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 19:1323–1330

    Article  PubMed  Google Scholar 

  • Glueck CJ, Goldenberg N, Wang P et al. (2004b) Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 19:510–521

    Article  PubMed  Google Scholar 

  • Haddow JE, Palomaki GE, Allan WC et al. (1999) Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341:549–555

    Article  PubMed  Google Scholar 

  • Harborne L, Fleming R, Lyall H et al. (2003) Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 88:4116–4123

    Article  PubMed  Google Scholar 

  • Jakubowicz DJ, Iuorno MJ, Jakubowicz S et al. (2002) Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 87:524–529

    Article  PubMed  Google Scholar 

  • Kocak M, Caliskan E, Simsir C et al. (2002) Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 77:101–106

    Article  PubMed  Google Scholar 

  • Leidenberger F (1997) Klinische Endokrinologie für Frauenärzte. Springer Verlag, Heidelberg

    Google Scholar 

  • Leung AS, Millar LK, Koonings PP et al. (1993) Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 81:349–353

    PubMed  Google Scholar 

  • Lord JM, Flight IH, Norman RJ (2003) Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev CD003053.

    Google Scholar 

  • Ludwig M, Felberbaum RE, Diedrich K (1999) Interactions of GnRH analogues and gonadotrophins. In: Adashi EY, Baird DT, Crosignani PG (Hrsg) Gonadotrophins and Fertility. 1 ed. Rom Christengraf 125–143

    Google Scholar 

  • Ludwig M, Strik D, Al-Hasani S et al. (1999) No transfer in a planned ICSI cycle: we cannot overcome some basic rules of human reproduction. Europ J Obstet Gynecol Reprod Biol 87:3–11

    Article  Google Scholar 

  • Ludwig M, Felberbaum RE, Bauer O et al. (1999) Ovarian abscess and heterotopic triplet pregnancy: two complications after IVF in one patient. Arch Gynecol Obstet 263:25–28

    Article  PubMed  Google Scholar 

  • Ludwig M, Jelkmann W, Bauer O et al. (1999) Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Hum Reprod 14:2437–2441

    Article  PubMed  Google Scholar 

  • Moghetti P, Castello R, Negri C et al. (2000) Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85:139–146

    Article  PubMed  Google Scholar 

  • Muratori M, Arosio M, Gambino G et al. (1997) Use of cabergoline in the long-term treatment of hyperprolactinemic and acromegalic patients. J Endocrinol Invest 20:537–546

    PubMed  Google Scholar 

  • Nestler JE, Powers LP, Matt DW (1991) A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72:83–89

    PubMed  Google Scholar 

  • Nestler JE, Jakubowicz DJ (1996) Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617–623

    Article  PubMed  Google Scholar 

  • Nestler JE, Jakubowicz DJ (1997) Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 82:4075–4079

    Article  PubMed  Google Scholar 

  • Nestler JE, Jakubowicz DJ, Evans WS et al. (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338:1876–1880

    Article  PubMed  Google Scholar 

  • Nestler JE, Stovall D, Akhter N et al. (2002) Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77:209–215

    Article  PubMed  Google Scholar 

  • Ng EH, Wat NM, Ho PC (2001) Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial. Hum Reprod 16:1625–1631

    Article  PubMed  Google Scholar 

  • Pascal-Vigneron V, Weryha G, Bosc M et al. (1995) Hyperprolactinemic amenorrhea:treatment with cabergoline versus bromocriptine. Results of a national multicenter randomized double-blind study. Presse Med 24:753–757

    PubMed  Google Scholar 

  • Pasquali R, Gambineri A, Biscotti D et al. (2000) Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 85:2767–2774

    Article  PubMed  Google Scholar 

  • Salpeter SR, Greyber E, Pasternak GA et al. (2003) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 163:2594–2602

    Article  PubMed  Google Scholar 

  • Smit BJ, Kok JH, Vulsma T et al. (2000) Neurologic development of the newborn and young child in relation to maternal thyroid function. Acta Paedriatr 89:291–295

    Article  Google Scholar 

  • Vandermolen DT, Ratts VS, Evans WS et al. (2001) Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 75:310–315

    Article  PubMed  Google Scholar 

  • Verhelst J, Abs R, Maiter D et al. (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84:2518–2522

    Article  PubMed  Google Scholar 

  • Webster J, Piscitelli G, Polli A et al. (1992) Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blind, multicentre study. European Multicentre Cabergoline Dose-finding Study Group. Clin Endocrinol (Oxf) 37:534–541

    Google Scholar 

  • Webster J, Piscitelli G, Polli A et al. (1994) A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med 331:904–909

    Article  PubMed  Google Scholar 

  • Wuttke W, Hinney B (1998) Die normale und gestörte Funktion des Corpus luteum. Reproduktionsmedizin 14:18–26

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

(2005). Hormonanalytik zur Zyklusdiagnostik. In: Kinderwunschsprechstunde. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26735-2_3

Download citation

  • DOI: https://doi.org/10.1007/3-540-26735-2_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-22422-8

  • Online ISBN: 978-3-540-26735-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation